Prevention of hepatocellular carcinoma in patients with chronic active hepatitis C and cirrhosis
Top Cited Papers
- 20 January 2001
- journal article
- research article
- Published by Elsevier
- Vol. 357 (9251) , 196-197
- https://doi.org/10.1016/s0140-6736(00)03595-9
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Interferon Therapy Reduces the Risk for Hepatocellular Carcinoma: National Surveillance Program of Cirrhotic and Noncirrhotic Patients with Chronic Hepatitis C in JapanAnnals of Internal Medicine, 1999
- Occult Hepatitis B Virus Infection in Patients with Chronic Hepatitis C Liver DiseaseNew England Journal of Medicine, 1999
- The Long–Term Outcomes of Patients With Compensated Hepatitis C Virus-Related Cirrhosis and History of Parenteral Exposure in the United StatesHepatology, 1999
- Effect of interferon-α on progression of cirrhosis to hepatocellular carcinoma: a retrospective cohort studyThe Lancet, 1998
- Randomised trial of effects of interferon-α on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosisPublished by Elsevier ,1995